MX385466B - Validacion de aclaramiento viral continuo. - Google Patents

Validacion de aclaramiento viral continuo.

Info

Publication number
MX385466B
MX385466B MX2019004540A MX2019004540A MX385466B MX 385466 B MX385466 B MX 385466B MX 2019004540 A MX2019004540 A MX 2019004540A MX 2019004540 A MX2019004540 A MX 2019004540A MX 385466 B MX385466 B MX 385466B
Authority
MX
Mexico
Prior art keywords
viral clearance
probe
validation
continuous viral
continuous
Prior art date
Application number
MX2019004540A
Other languages
English (en)
Spanish (es)
Other versions
MX2019004540A (es
Inventor
Benjamin Maiser
Laura David
Martin Lobedann
Peter Schwan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX2019004540A publication Critical patent/MX2019004540A/es
Publication of MX385466B publication Critical patent/MX385466B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22Testing for sterility conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029Radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
MX2019004540A 2016-10-21 2017-10-19 Validacion de aclaramiento viral continuo. MX385466B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16194959.9A EP3141611A3 (en) 2016-10-21 2016-10-21 Validation of continuous viral clearance
PCT/US2017/057298 WO2018075716A1 (en) 2016-10-21 2017-10-19 Validation of continuous viral clearance

Publications (2)

Publication Number Publication Date
MX2019004540A MX2019004540A (es) 2019-06-12
MX385466B true MX385466B (es) 2025-03-18

Family

ID=57209212

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019004540A MX385466B (es) 2016-10-21 2017-10-19 Validacion de aclaramiento viral continuo.

Country Status (16)

Country Link
US (1) US10894991B2 (cg-RX-API-DMAC7.html)
EP (2) EP3141611A3 (cg-RX-API-DMAC7.html)
JP (1) JP2019537435A (cg-RX-API-DMAC7.html)
KR (1) KR20190066017A (cg-RX-API-DMAC7.html)
CN (1) CN110100008A (cg-RX-API-DMAC7.html)
AR (1) AR109846A1 (cg-RX-API-DMAC7.html)
AU (1) AU2017345412A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019007835A2 (cg-RX-API-DMAC7.html)
CA (1) CA3041253A1 (cg-RX-API-DMAC7.html)
IL (1) IL266095A (cg-RX-API-DMAC7.html)
MX (1) MX385466B (cg-RX-API-DMAC7.html)
RU (1) RU2755634C2 (cg-RX-API-DMAC7.html)
SG (1) SG10202104023QA (cg-RX-API-DMAC7.html)
TW (1) TW201827830A (cg-RX-API-DMAC7.html)
UY (1) UY37447A (cg-RX-API-DMAC7.html)
WO (1) WO2018075716A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019011900A1 (en) * 2017-07-10 2019-01-17 Baxalta Incorporated METHOD FOR LIQUID INCUBATION AND VIRUS INACTIVATION
EP4112735A4 (en) * 2020-02-28 2023-09-06 Asahi Kasei Medical Co., Ltd. Method for evaluating viral clearance performance
CN116261566A (zh) * 2020-09-21 2023-06-13 拜耳医药保健有限责任公司 病原体清除系统和方法
US12203914B2 (en) * 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
EP4317460B1 (en) * 2021-03-26 2025-12-31 Asahi Kasei Life Science Corporation VIRAL CLEARANCE TEST PROCEDURE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184833A1 (en) * 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
AU2014100888A4 (en) * 2014-08-07 2014-09-11 Novartis Ag Virus clearance and protein purification methods

Also Published As

Publication number Publication date
CN110100008A (zh) 2019-08-06
EP3529367A1 (en) 2019-08-28
AU2017345412A1 (en) 2019-04-18
MX2019004540A (es) 2019-06-12
IL266095A (en) 2019-06-30
CA3041253A1 (en) 2018-04-26
RU2755634C2 (ru) 2021-09-17
US20190316213A1 (en) 2019-10-17
KR20190066017A (ko) 2019-06-12
JP2019537435A (ja) 2019-12-26
WO2018075716A1 (en) 2018-04-26
RU2019115375A3 (cg-RX-API-DMAC7.html) 2021-03-19
SG10202104023QA (en) 2021-06-29
EP3141611A2 (en) 2017-03-15
US10894991B2 (en) 2021-01-19
BR112019007835A2 (pt) 2019-10-01
UY37447A (es) 2018-05-31
EP3141611A3 (en) 2017-05-10
RU2019115375A (ru) 2020-11-23
AR109846A1 (es) 2019-01-30
TW201827830A (zh) 2018-08-01

Similar Documents

Publication Publication Date Title
MX385466B (es) Validacion de aclaramiento viral continuo.
IL256644B (en) System and method for management, execution, and analysis of laboratory experiments
EP3327198A4 (en) RISS ANALYSIS DEVICE, RIP ANALYSIS METHOD AND RIP ANALYSIS PROGRAM
CL2014002551A1 (es) Metodo para identificar segmento de audio, que comprende las etapas de crear un espectrograma del segmento candidato de audio, crear un mapa candidato de bits huella digital y acustica del espectrograma, comparar el mapa candidato con al menos un mapa conocido de un mensaje de red conocido, si el mapa candidato coincide con un mapa conocido, declarar el calce, y si el candidato no coincide, utilizar un algoritmo de deteccion para analizar el segmento de audio candidato; metodos asociados.
EP3344977C0 (en) METHOD AND SYSTEM FOR ANALYZING SAMPLES USING LASER-INDUCED BREAKDOWN SPECTROSCOPY
EA201990986A1 (ru) Способы и системы анализа хроматографических данных
EP3516563A4 (en) A system and method to analyze and improve sports performance using monitoring devices
EA201790214A1 (ru) Определение одного или нескольких параметров проекта заканчивания скважины на основании данных бурения, соответствующих переменным удельной механической энергии
MX2017006097A (es) Libs para caracterizacion de fluido de materiales porosos.
EP4250151A4 (en) ATTACK ANALYSIS DEVICE, ATTACK ANALYSIS METHOD, AND PROGRAM
EP3439277A4 (en) DISC MANAGEMENT SYSTEM AND DISC MANAGEMENT PROCESS
EP3702942A4 (en) ANALYSIS SYSTEM, ANALYSIS METHOD AND PROGRAM
EP3889797A4 (en) DATABASE INDEX AND DATABASE QUERY PROCESSING METHOD, APPARATUS AND DEVICE
EP3796249A4 (en) Specimen examination management device, specimen examination management system, specimen examination management method, and program
EP3297703A4 (en) PHOTOTHERAPY SYSTEM AND METHOD FOR PREVENTING OR TREATING CARBON MONOXIDE POISONING
AU2016334875A8 (en) Blood preparation and profiling
JP2019537435A5 (cg-RX-API-DMAC7.html)
EP3540043A4 (en) ANALYSIS DEVICE, ANALYSIS METHOD, AND PROGRAM
EP2991265A4 (en) SYSTEM, METHOD AND PROGRAM FOR ADAPTING ENCRYPTED TEXTS
EP3839780A4 (en) DETECTOR, DETECTION METHOD AND DETECTION PROGRAM
DK3207374T3 (da) Fremgangsmåde og system til bestemmelse af koncentrationen af en analyt i en fluidprøve
EP3731108A4 (en) RESEARCH SYSTEM, RESEARCH PROCESS AND PROGRAM
EP3683693A4 (en) SAMPLE CATEGORY IDENTIFICATION DEVICE, ANALYTICAL SYSTEM AND ANALYTICAL NETWORK SYSTEM
EP3916655A4 (en) OPERATIONAL ANALYSIS DEVICE, OPERATIONAL ANALYSIS METHOD, OPERATIONAL ANALYSIS PROGRAM, AND OPERATIONAL ANALYSIS SYSTEM
EP2991266A4 (en) SYSTEM, METHOD AND PROGRAM FOR ADAPTING ENCRYPTED TEXTS